<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: ms</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>What part do relapses play in severe disability for people with MS?</title>
   	 <description>ST. PAUL, Minn. -People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology(R), the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.</description>
     <link>http://www.physorg.com/news176579798.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 04 Nov 2009 18:10:02 EST</pubDate>
	 <guid isPermaLink="false">news176579798</guid>
</item>
<item>
     <title>Aussie and Kiwi researchers make double MS genetic discovery</title>
   	 <description>Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.</description>
     <link>http://www.physorg.com/news164207328.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 14 Jun 2009 14:09:32 EST</pubDate>
	 <guid isPermaLink="false">news164207328</guid>
</item>
<item>
     <title>Risk of leukemia with multiple sclerosis drug higher than thought</title>
   	 <description>The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009.</description>
     <link>http://www.physorg.com/news160307791.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 11:00:07 EST</pubDate>
	 <guid isPermaLink="false">news160307791</guid>
</item>
<item>
     <title>Adding steroid drug to MS treatment may reduce disease activity</title>
   	 <description>Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009.</description>
     <link>http://www.physorg.com/news160307373.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 10:50:32 EST</pubDate>
	 <guid isPermaLink="false">news160307373</guid>
</item>
<item>
     <title>New pill to treat multiple sclerosis</title>
   	 <description>A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.</description>
     <link>http://www.physorg.com/news160274531.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 01:42:40 EST</pubDate>
	 <guid isPermaLink="false">news160274531</guid>
</item>
<item>
     <title>Stem cells from fat tissue offer hope for MS treatment</title>
   	 <description>A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open access Journal of Translational Medicine support further clinical evaluation of stromal vascular fraction (SVF) cells in MS and other autoimmune conditions.</description>
     <link>http://www.physorg.com/news159776574.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 24 Apr 2009 07:23:23 EST</pubDate>
	 <guid isPermaLink="false">news159776574</guid>
</item>
<item>
     <title>'Buckyballs' to treat multiple sclerosis</title>
   	 <description>If you're of a certain age, you'll remember Buckminster Fuller's distinctive "geodesic domes" - soccer-ball-shaped structures that the late futurist envisioned as ideal human domiciles. Tel Aviv University chemists remember them too - and are now putting them to use in the treatment of multiple sclerosis (MS).</description>
     <link>http://www.physorg.com/news156706234.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Thu, 19 Mar 2009 18:31:13 EST</pubDate>
	 <guid isPermaLink="false">news156706234</guid>
</item>
<item>
     <title>Hookworms in MS trial</title>
   	 <description>Scientists from The University of Nottingham will study the potential health benefits of parasitic worms as part of a study investigating treatments for people with the autoimmune condition multiple sclerosis (MS).</description>
     <link>http://www.physorg.com/news155329936.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 03 Mar 2009 19:12:54 EST</pubDate>
	 <guid isPermaLink="false">news155329936</guid>
</item>
<item>
     <title>Epstein-Barr virus may be associated with progression of MS</title>
   	 <description>Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University of Trieste, Italy, have shown.</description>
     <link>http://www.physorg.com/news155229747.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Mar 2009 15:22:54 EST</pubDate>
	 <guid isPermaLink="false">news155229747</guid>
</item>
<item>
     <title>Drug improves mobility for some MS patients</title>
   	 <description>The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS).  That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The Lancet.</description>
     <link>http://www.physorg.com/news154938328.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 27 Feb 2009 06:26:14 EST</pubDate>
	 <guid isPermaLink="false">news154938328</guid>
</item>
<item>
     <title>Young smokers increase risk for multiple sclerosis</title>
   	 <description>People who start smoking before age 17 may increase their risk for developing multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009. </description>
     <link>http://www.physorg.com/news154618005.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Feb 2009 13:27:17 EST</pubDate>
	 <guid isPermaLink="false">news154618005</guid>
</item>
<item>
     <title>Can breastfeeding reduce multiple sclerosis relapses?</title>
   	 <description>Women who have multiple sclerosis may reduce their risk of relapses after pregnancy if they breastfeed their babies, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009.</description>
     <link>http://www.physorg.com/news154283391.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Feb 2009 16:30:14 EST</pubDate>
	 <guid isPermaLink="false">news154283391</guid>
</item>
<item>
     <title>Genetic study shows direct link between vitamin D and MS susceptibility 'gene'</title>
   	 <description>Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS). The research, published on 6 February in the open-access journal PLoS Genetics, suggests that vitamin D deficiency during pregnancy and the early years may increase the risk of the offspring developing MS later in life.</description>
     <link>http://www.physorg.com/news153064682.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 05 Feb 2009 14:00:24 EST</pubDate>
	 <guid isPermaLink="false">news153064682</guid>
</item>
<item>
     <title>Relapses more frequent in patients diagnosed with pediatric-onset multiple sclerosis</title>
   	 <description>Patients who develop multiple sclerosis before age 18 appear to experience more relapses of symptoms than those diagnosed with the disease as adults, according to a report in the January issue of Archives of Neurology.</description>
     <link>http://www.physorg.com/news151001543.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Jan 2009 16:52:23 EST</pubDate>
	 <guid isPermaLink="false">news151001543</guid>
</item>
<item>
     <title>If MRI shows signs of MS, will the disease develop?</title>
   	 <description>With more and more people having brain MRIs for various reasons, doctors are finding people whose scans show signs of multiple sclerosis (MS) even though they have no symptoms of the disease. A new study published in the December 10, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology, found that a third of these people developed MS within an average of about five years.</description>
     <link>http://www.physorg.com/news148150423.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Dec 2008 16:53:43 EST</pubDate>
	 <guid isPermaLink="false">news148150423</guid>
</item>
<item>
     <title>In the war against diseases, nerve cells need their armor</title>
   	 <description>In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons). Up until now, very little was known about myelin maintenance. This new information provides vital insight into diseases such as Multiple Sclerosis (MS) and other progressive demyelinating diseases in which myelin is destroyed, causing irreversible damage and disrupting the nerve cells' ability to transmit messages. </description>
     <link>http://www.physorg.com/news145708456.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 12 Nov 2008 10:34:16 EST</pubDate>
	 <guid isPermaLink="false">news145708456</guid>
</item>
<item>
     <title>Revealed: alcohol's relentless grasp on women</title>
   	 <description>New research from the University of Western Sydney has revealed that women in recovery from alcoholism are at a high risk of relapsing as they reach midlife.</description>
     <link>http://www.physorg.com/news144948706.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Nov 2008 15:31:46 EST</pubDate>
	 <guid isPermaLink="false">news144948706</guid>
</item>
<item>
     <title>Obesity, other health problems delay MS diagnosis</title>
   	 <description>People with pre-existing medical conditions, such as obesity, and vascular problems such as diabetes, high blood pressure or high cholesterol, may experience a delay in being diagnosed with multiple sclerosis (MS), or experience an increase in severity of the disease at diagnosis, according to a study published in the October 29, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news144513954.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Oct 2008 15:45:54 EST</pubDate>
	 <guid isPermaLink="false">news144513954</guid>
</item>
<item>
     <title>MS patients have higher spinal fluid levels of suspicious immune molecule</title>
   	 <description>A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.</description>
     <link>http://www.physorg.com/news141917026.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 29 Sep 2008 14:23:46 EST</pubDate>
	 <guid isPermaLink="false">news141917026</guid>
</item>
<item>
     <title>Majority of children vaccinated against hepatitis B not at increased risk of MS</title>
   	 <description>The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study to be published in the October 8, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news141568947.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Sep 2008 13:42:27 EST</pubDate>
	 <guid isPermaLink="false">news141568947</guid>
</item>
<item>
     <title>Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model</title>
   	 <description>In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Würzburg have been able to visualize inflammatory tissue damage, most of which had remained unrecognized up to now, with the aid of a new contrast medium, Gadofluorine M, in magnetic resonance imaging. The scientists have published their results in the online edition of the renowned medical journal Brain.</description>
     <link>http://www.physorg.com/news136807352.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 01 Aug 2008 11:02:32 EST</pubDate>
	 <guid isPermaLink="false">news136807352</guid>
</item>
<item>
     <title>Milestone for cannabinoid MS study</title>
   	 <description>The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.</description>
     <link>http://www.physorg.com/news135859720.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Jul 2008 11:48:40 EST</pubDate>
	 <guid isPermaLink="false">news135859720</guid>
</item>
<item>
     <title>Best treatment for MS may depend on disease subtype</title>
   	 <description>Animal studies by University of Michigan scientists suggest that people who experience the same clinical signs of multiple sclerosis (MS) may have different forms of the disease that require different kinds of treatment.</description>
     <link>http://www.physorg.com/news134147197.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Jul 2008 16:06:37 EST</pubDate>
	 <guid isPermaLink="false">news134147197</guid>
</item>
<item>
     <title>Wake up and smell the coffee: Study finds that caffeine may help prevent MS</title>
   	 <description>A good cup of coffee might be just the wake-up call scientists need to stop multiple sclerosis.</description>
     <link>http://www.physorg.com/news134065007.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Jun 2008 17:16:47 EST</pubDate>
	 <guid isPermaLink="false">news134065007</guid>
</item>


</channel>
</rss>

